3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
158
Lymphoma
156
Precursor Cell Lymphoblastic Leukemia-Lymphoma
130
Lymphoma, Non-Hodgkin
120
Leukemia
119
Leukemia, Lymphocytic, Chronic, B-Cell
116
Multiple Myeloma
115
Lymphoma, Large B-Cell, Diffuse
100
Leukemia, Myeloid, Acute
97
Hodgkin Disease
82
Myelodysplastic Syndromes
78
Lymphoma, Follicular
74
Lymphoma, Mantle-Cell
72
Burkitt Lymphoma
66
Lymphoma, B-Cell, Marginal Zone
52
Melanoma
49
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
48
Neoplasms
45
Recurrence
38
Hematologic Neoplasms
34
Lymphoma, Large-Cell, Immunoblastic
33
Myeloproliferative Disorders
31
Congenital Abnormalities
31
Waldenstrom Macroglobulinemia
30
Neoplasms, Plasma Cell
30
Leukemia, Myelomonocytic, Chronic
30
Lymphoma, B-Cell
29
Primary Myelofibrosis
27
Lymphoma, Large-Cell, Anaplastic
27
Leukemia, Myeloid, Accelerated Phase
26
Interventions
Bevacizumab
3
ribociclib
2
Temozolomide
2
Radiotherapy
2
Radiation
2
Panobinostat
2
pembrolizumab
1
dipinacoline glutamate
1
dinutuximab
1
cemiplimab
1
adavosertib
1
abemaciclib
1
Vorinostat
1
Valproic Acid
1
Re-Irradiation
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Nivolumab
1
Maintenance
1
Irinotecan
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Everolimus
1
Erlotinib Hydrochloride
1
Congresses as Topic
1
Chemotherapy, Adjuvant
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diffuse Intrinsic Pontine Glioma
×
Cyclophosphamide
×
Clear all
No trials found.